150 related articles for article (PubMed ID: 15225622)
21. The interaction of amyloid Abeta(1-40) with lipid bilayers and ganglioside as studied by 31P solid-state NMR.
Nakazawa Y; Suzuki Y; Williamson MP; Saitô H; Asakura T
Chem Phys Lipids; 2009 Mar; 158(1):54-60. PubMed ID: 19138679
[TBL] [Abstract][Full Text] [Related]
22. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease.
Huang Y
Trends Mol Med; 2010 Jun; 16(6):287-94. PubMed ID: 20537952
[TBL] [Abstract][Full Text] [Related]
23. Age-dependent high-density clustering of GM1 ganglioside at presynaptic neuritic terminals promotes amyloid beta-protein fibrillogenesis.
Yamamoto N; Matsubara T; Sato T; Yanagisawa K
Biochim Biophys Acta; 2008 Dec; 1778(12):2717-26. PubMed ID: 18727916
[TBL] [Abstract][Full Text] [Related]
24. Isoform-specific effect of apolipoprotein E on endocytosis of beta-amyloid in cultures of neuroblastoma cells.
Yamauchi K; Tozuka M; Hidaka H; Nakabayashi T; Sugano M; Katsuyama T
Ann Clin Lab Sci; 2002; 32(1):65-74. PubMed ID: 11848621
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
Donahue JE; Johanson CE
J Neuropathol Exp Neurol; 2008 Apr; 67(4):261-70. PubMed ID: 18379441
[TBL] [Abstract][Full Text] [Related]
26. Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-beta peptide.
Stratman NC; Castle CK; Taylor BM; Epps DE; Melchior GW; Carter DB
Chem Phys Lipids; 2005 Oct; 137(1-2):52-61. PubMed ID: 16140289
[TBL] [Abstract][Full Text] [Related]
27. Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.
Mann KM; Thorngate FE; Katoh-Fukui Y; Hamanaka H; Williams DL; Fujita S; Lamb BT
Hum Mol Genet; 2004 Sep; 13(17):1959-68. PubMed ID: 15229191
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein-E modulates the cytotoxic effect of beta-amyloid on rat brain endothelium in an isoform-dependent specific manner.
Folin M; Baiguera S; Guidolin D; Di Liddo R; Grandi C; De Carlo E; Nussdorfer GG; Parnigotto PP
Int J Mol Med; 2006 May; 17(5):821-6. PubMed ID: 16596266
[TBL] [Abstract][Full Text] [Related]
29. A 13 kDa carboxy-terminal fragment of ApoE stabilizes Abeta hexamers.
Wellnitz S; Friedlein A; Bonanni C; Anquez V; Goepfert F; Loetscher H; Adessi C; Czech C
J Neurochem; 2005 Sep; 94(5):1351-60. PubMed ID: 16011742
[TBL] [Abstract][Full Text] [Related]
30. Gangliosides determine the amyloid pathology of Alzheimer's disease.
Oikawa N; Yamaguchi H; Ogino K; Taki T; Yuyama K; Yamamoto N; Shin RW; Furukawa K; Yanagisawa K
Neuroreport; 2009 Aug; 20(12):1043-6. PubMed ID: 19590389
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of amyloid β-protein aggregation mediated by GM1 ganglioside clusters.
Ikeda K; Yamaguchi T; Fukunaga S; Hoshino M; Matsuzaki K
Biochemistry; 2011 Jul; 50(29):6433-40. PubMed ID: 21682276
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
[TBL] [Abstract][Full Text] [Related]
33. Ganglioside G(M1)-mediated amyloid-beta fibrillogenesis and membrane disruption.
Chi EY; Frey SL; Lee KY
Biochemistry; 2007 Feb; 46(7):1913-24. PubMed ID: 17256880
[TBL] [Abstract][Full Text] [Related]
34. [Risk factors for Alzheimer's disease].
Yanagisawa K
Rinsho Shinkeigaku; 2000 Dec; 40(12):1225-7. PubMed ID: 11464462
[TBL] [Abstract][Full Text] [Related]
35. Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice.
Thal DR; Larionov S; Abramowski D; Wiederhold KH; Van Dooren T; Yamaguchi H; Haass C; Van Leuven F; Staufenbiel M; Capetillo-Zarate E
Neurobiol Aging; 2007 Aug; 28(8):1221-30. PubMed ID: 16815595
[TBL] [Abstract][Full Text] [Related]
36. [Pathological implications of GM1 ganglioside-bound amyloid beta-protein in Alzheimer's disease].
Yanagisawa K
Tanpakushitsu Kakusan Koso; 2002 Mar; 47(4 Suppl):344-50. PubMed ID: 11915325
[No Abstract] [Full Text] [Related]
37. Role of gangliosides in Alzheimer's disease.
Yanagisawa K
Biochim Biophys Acta; 2007 Aug; 1768(8):1943-51. PubMed ID: 17321494
[TBL] [Abstract][Full Text] [Related]
38. Midazolam inhibits the formation of amyloid fibrils and GM1 ganglioside-rich microdomains in presynaptic membranes through the gamma-aminobutyric acid A receptor.
Yamamoto N; Arima H; Sugiura T; Hirate H; Kusama N; Suzuki K; Sobue K
Biochem Biophys Res Commun; 2015 Feb; 457(4):547-53. PubMed ID: 25600806
[TBL] [Abstract][Full Text] [Related]
39. Brain insulin resistance accelerates Aβ fibrillogenesis by inducing GM1 ganglioside clustering in the presynaptic membranes.
Yamamoto N; Matsubara T; Sobue K; Tanida M; Kasahara R; Naruse K; Taniura H; Sato T; Suzuki K
J Neurochem; 2012 May; 121(4):619-28. PubMed ID: 22260232
[TBL] [Abstract][Full Text] [Related]
40. Increased cholesterol in Abeta-positive nerve terminals from Alzheimer's disease cortex.
Gylys KH; Fein JA; Yang F; Miller CA; Cole GM
Neurobiol Aging; 2007 Jan; 28(1):8-17. PubMed ID: 16332401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
